Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation

Recruiting

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(15 sites)

Canada

Libin Cardiovascular Institute, Calgary, Alberta

Vancouver General Hospital, Vancouver, British Columbia

QEII Health Sciences Centre, Nova Scotia Health Authority, Halifax, Nova Scotia

Hamilton General Hospital, Hamilton, Ontario

London Health Sciences Centre, London, Ontario

Southlake Regional Health Centre, Newmarket, Ontario

University of Ottawa Heart Institute, Ottawa, Ontario

St. Michael's Hospital, Toronto, Ontario

Rouge Valley Regional Heart Centre, Toronto, Ontario

Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal, Quebec

Sacre-Coeur Hospital, Montreal, Quebec

McGill University Health Centre, Montreal, Quebec

Montreal Heart Institute, Montreal, Quebec

Institute Universitaire de Cardiologie et Pneumologie du Quebec (IUCPQ), Québec, Quebec

CIUSSS de L'Estrie-CHUS-Hopital Fleurimont, Sherbrooke, Quebec